EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Passive Immunization in the Prevention and Treatment of Viral Infections

Romila Moirangthem, Yotam Bar-On

European Journal of Immunology · 2025-05 · 55 (5)

DOI: 10.1002/eji.202451606 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Immunology, online erschienen am 25.05.2025. Verfasst von Romila Moirangthem und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. Hauptthemen laut MEDLINE: Immunization, Passive, COVID-19, SARS-CoV-2, Respiratory Syncytial Virus Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The basic concepts of passive immunization and the potential of antibody therapy to confer immunity against infectious diseases were introduced already in the late 19th century. This approach was also later implemented to extensively treat and prevent infections, but with the development of effective vaccines, it became restricted to only a few medical conditions such as snake bites, neutralization of toxins, and prevention of rabies infection. This has dramatically changed in the last decade, as antibodies have been widely used in the clinic for the treatment of COVID‐19 and the prevention of respiratory syncytial virus (RSV) infections. A stepping‐stone for the progress in monoclonal antibody generation was the development of single‐cell antibody cloning techniques that made it possible to develop effective neutralizing antibodies against highly mutable viruses such as influenza virus and HIV‐1. Here, we review the use of passive immunotherapy in the clinic for treating and controlling SARS‐CoV‐2 and RSV infections. We further discuss key developments that have made it possible to use monoclonal antibodies against the highly mutable HIV‐1 and influenza virus and advanced clinical trials designed to evaluate the efficacy of such an approach. Finally, we present recent findings that demonstrate that passive immunization can elicit long‐term immunity in the host.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunization, PassiveCOVID-19SARS-CoV-2Respiratory Syncytial Virus InfectionsAntibodies, ViralHumansAntibodies, MonoclonalAnimalsAntibodies, NeutralizingHIV-1

Stichwörter der Autor:innen

antibodiespassive immunizationviral immunityviruses

Substanzen

Antibodies, MonoclonalAntibodies, ViralAntibodies, Neutralizing

Autor:innen und Institutionen

  • Department of Immunology, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Zitieren

APA

Moirangthem, R., & Bar-On, Y. (2025). Passive Immunization in the Prevention and Treatment of Viral Infections. European Journal of Immunology, 55(5). https://doi.org/10.1002/eji.202451606

Vancouver

Moirangthem R, Bar-On Y. Passive Immunization in the Prevention and Treatment of Viral Infections. European Journal of Immunology. 2025;55(5). doi:10.1002/eji.202451606

BibTeX
@article{Moirangthem2025,
  author = {Moirangthem, Romila and Bar-On, Yotam},
  title = {Passive Immunization in the Prevention and Treatment of Viral Infections},
  journal = {European Journal of Immunology},
  year = {2025},
  volume = {55},
  number = {5},
  doi = {10.1002/eji.202451606}
}
Kostenlos starten →